Our study demonstrated that MSCs overexpressing DCN can enhance the therapeutic effect on BLM-induced pulmonary fibrosis in rats by inhibiting inflammation and fibrosis deposition in the lung tissue and allowing rats to regain body weight. Here, DCN is linked to pulmonary fibrosis.